首页 | 本学科首页   官方微博 | 高级检索  
     


Frequency,risk factors,and outcomes of central nervous system relapse in lymphoma patients treated with dose‐adjusted EPOCH plus rituximab
Authors:Mary‐Kate Malecek  Adam M. Petrich  Shaina Rozell  Benjamin Chu  Steven Trifilio  Natalie Galanina  Matthew Maurer  Umar Farooq  Brian K. Link  Grzegorz S. Nowakowski  Chadi Nabhan  Ayed O. Ayed
Affiliation:1. Department of Medicine, Northwestern University, Chicago, Illinois;2. Division of Hematology/Oncology, Northwestern University, Chicago, Illinois;3. Northwestern University Feinberg School of Medicine, Chicago, Illinois;4. Division of Hematology/Oncology, University of Chicago, Chicago, Illinois;5. Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota;6. Division of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, Iowa;7. Division of Hematology, Mayo Clinic, Rochester, Minnesota;8. Cardinal Health, Inc, Dublin, Ohio
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号